TSH Biopharm Corporation Limited
Research TSH Biopharm Corporation Limited (8432.TWO) on Bullrun: market cap TWD 2.16B, P/E 12.9, dividend yield 4.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker8432.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyTWD
- Market capTWD 2.16B
- P/E12.9
- Dividend yield4.2%
- Financial periodQ2 2026
- RevenueTWD 330.69M
- Net incomeTWD 45.85M
- Free cash flowTWD 42.59M
- Gross margin55.5%
Valuation Snapshot
latest market cap is TWD 2.16B; P/E is 12.9; dividend yield is 4.2%.
Peer valuation comparison
Latest P/E is 12.92x versus a Healthcare sector median of 21.8x (40.7% below).
Latest dividend yield is 4.22% versus a Healthcare sector median of 2.4% (75.8% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 2.16B | 12.9 | 4.6% | 2.61 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.61 TWD, yield 4.2%.
About TSH Biopharm Corporation Limited
TSH Biopharm Corporation Limited develops and markets pharmaceutical products in Taiwan. The company offers prescription medication for cardiovascular, central nervous, gastrointestinal, and others. It also provides MPap, a methylation-specific qPCR technology to detect the methylation status of CDO1 and BHLHE22 genes using cervical scraping; AlphaLiquid Detect, a hybrid capture NGS-based liquid biopsy test designed for MRD detection and surveillance in stage I-III solid tumor patients;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is TSH Biopharm Corporation Limited's market cap?
TSH Biopharm Corporation Limited's market capitalization is TWD 2.16B.
What is TSH Biopharm Corporation Limited's P/E ratio?
TSH Biopharm Corporation Limited's price-to-earnings (P/E) ratio is 12.9.
Does TSH Biopharm Corporation Limited pay a dividend?
TSH Biopharm Corporation Limited has a dividend yield of 4.2%.
What does TSH Biopharm Corporation Limited do?
TSH Biopharm Corporation Limited develops and markets pharmaceutical products in Taiwan. The company offers prescription medication for cardiovascular, central nervous, gastrointestinal, and others.